Document is current

Any future updates will be listed below

Efficacy of dulaglutide after switching from incretin-related drugs in patients with type 2 diabetes and inadequate glycemic control

Crossref DOI link: https://doi.org/10.1007/s13340-021-00508-3

Published Online: 2021-04-29

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark